NASDAQ Healthcare Medical - Instruments & Supplies POCI

Precision Optics Corporation, Inc.

$ 5.72 -1.21 %

Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.

CEO: Joseph N. Forkey - https://www.poci.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ -21.60

Loading data...

POCI vs S&P500

Loading data...

No data available.

Quick ratio

1.74

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

-8.94

may indicate that the company is undervalued or has poor growth prospects.

EPS

-0.64

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-37.47 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

-19.51 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

5.47

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.21

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

-0.24

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
0.23 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
1.05 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.13 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.